Tadbelt n wučči d isafaren
Tadbelt n wučči d isafaren (S Tegnizit: Food and Drug Administration - s usegzel: FDA neɣ USFDA) d tanegga yeṭṭafaren aɣlif n Iwunak Yeddukklen n Temrikt i yimeẓla n tdawsa d izerfan n wemdan. Akken i tga d yiwet gar tdeblin tiselkamin tifidiṛalyin deg Marikan.[1][2][3] Tadbelt n wučči d isafaren i d (tamasayt) ɣef taggaẓt d usnerni n tdawsa tamatut s ferru d waggal (asefqed) ɣef tɣellist n wučči d ifarisen n ubaɣa d tsutay d isafaren d yicraṭen d tnegwa tisnudranin d temhalin n tufkit n idammen d tinezririn
 Tadbelt n wučči d isafaren | |
|---|---|
 | |
.jpg) | |
| Isefka | |
| Isem amaddud |
Food and Drug Administration |
| Isem asgezlan | FDA |
| Anaw |
agence fédérale des États-Unis (fr)  d organisation de sécurité alimentaire (fr) |
| Tamurt | Iwunak Yeddukklen n Temrikt |
| Armud | |
| Agmam deg | ORCID |
| Amur seg |
département de la Santé et des Services sociaux des États-Unis (fr) |
| Analam |
Center for Biologics Evaluation and Research (en) , Center for Devices and Radiological Health (en) , Center for Drug Evaluation and Research (en) , Center for Food Safety and Applied Nutrition (en) , Center for Veterinary Medicine (en) , National Center for Toxicological Research (en) d Center for Tobacco Products (en) |
| Nombre d’employés (fr) | 17 468 (2018) |
| Langue utilisée (fr) | Taglizit |
| Tinnebṭit | |
| Aselway |
Janet Woodcock (fr) |
| Asutel amatu |
White Oak (fr) |
| Imlan |
département de la Santé et des Services sociaux des États-Unis (fr) |
| Propriétaire de (fr) |
IPLEDGE (fr) |
| Financial data | |
| Budget (fr) | 6 500 000 000 $ (2022) |
| Amezruy | |
| Asnulfu | 30 Yunyu 1906 |
| Asebdad | |
   | |
Asadaf n wučči d isafaren d tnezririn
ẓregẒeṛ daɣen
ẓreg- ↑ Ridley DB, Grabowski HG, Moe JL (2006). "Developing drugs for developing countries". Health Aff (Millwood). 25 (2): 313–24. doi:10.1377/hlthaff.25.2.313. PMID 16522573. Unknown parameter
|akala n ufaylu=ignored (help); Unknown parameter|azmez n ufaylu=ignored (help) - ↑ MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Accessed October 9, 2007 Archived 2018-01-03 at the Wayback Machine
- ↑ Nelson, LS; Loh, M; Perrone, J (June 2014). "Assuring safety of inherently unsafe medications: the FDA risk evaluation and mitigation strategies". Journal of medical toxicology : official journal of the American College of Medical Toxicology. 10 (2): 165–72. doi:10.1007/s13181-013-0374-z. PMC 4057549. PMID 24414251.